7 August 2023 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
10 July 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
14 June 2023 - SMC has collaborated with NICE on Technology Appraisal, TA900: tixagevimab-cilgavimab for preventing COVID-19. ...
12 June 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
30 May 2023 - Following a positive stakeholder evaluation, a change to SMC process for medicines introduced on an interim ...
9 May 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
13 March 2023 - The SMC which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
13 February 2023 - The SMC has approved the use of the drug pembrolizumab – which is also known as ...
13 February 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
8 February 2023 - A process brought in to streamline decision-making around access to new medicines in NHSScotland during the ...
26 January 2023 - SMC, as part of Healthcare Improvement Scotland, are part of an international collaboration. ...
18 January 2023 - Therapy is the first oral MET inhibitor treatment option for certain advanced NSCLC adult patients ...
16 January 2023 - The Scottish Medicines Consortium, which advises on newly-licensed medicines for use by NHSScotland, has today published ...
25 November 2022 - NICE and SMC/HIS collaboration on the health technology appraisal of tixagevimab–cilgavimab (Evusheld) for preventing COVID-19. ...
11 October 2022 - Scotland has become the first country in the UK to back NHS funding for the use ...